[go: up one dir, main page]

WO1996034884A3 - Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use - Google Patents

Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use Download PDF

Info

Publication number
WO1996034884A3
WO1996034884A3 PCT/SI1996/000011 SI9600011W WO9634884A3 WO 1996034884 A3 WO1996034884 A3 WO 1996034884A3 SI 9600011 W SI9600011 W SI 9600011W WO 9634884 A3 WO9634884 A3 WO 9634884A3
Authority
WO
WIPO (PCT)
Prior art keywords
gallisepticum
preparation
antibodies
mycoplasma
native
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SI1996/000011
Other languages
French (fr)
Other versions
WO1996034884A2 (en
Inventor
Janko Kos
Dusan Bencina
Dusan Dovc
Franc Gubensek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Jozef Stefan
Original Assignee
Institut Jozef Stefan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Jozef Stefan filed Critical Institut Jozef Stefan
Priority to AU54140/96A priority Critical patent/AU5414096A/en
Priority to GB9723289A priority patent/GB2314560B/en
Priority to DE19681356T priority patent/DE19681356T1/en
Publication of WO1996034884A2 publication Critical patent/WO1996034884A2/en
Publication of WO1996034884A3 publication Critical patent/WO1996034884A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention describes novel synthetic peptides imitating natural epitopes on the membrane of pathogenic mycoplasma M. gallisepticum and a process for the preparation thereof. By the mentioned peptides native antigens in serological tests can be substituted and they can be used as vaccines or as antigens for the preparation of antibodies. Antibodies prepared by means of these peptides recognize native mycoplasma epitopes and are useful in various diagnostic tests for determination of poultry infections with M. gallisepticum, they prevent the growth of the mentioned mycoplasma and are also suitable for the isolation of native or recombinant main immunogenic protein pMGA or its subunits.
PCT/SI1996/000011 1995-05-05 1996-04-29 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use Ceased WO1996034884A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU54140/96A AU5414096A (en) 1995-05-05 1996-04-29 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
GB9723289A GB2314560B (en) 1995-05-05 1996-04-29 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use
DE19681356T DE19681356T1 (en) 1995-05-05 1996-04-29 New synthetic peptides and their antibodies, their production and use in diagnosis and therapy of M. gallisepticum

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SIP-9500155 1995-05-05
SI9500155A SI9500155A (en) 1995-05-05 1995-05-05 Novel synthetic peptides and their antibodies, their prepatation and use in diagnostics and therapy of m. gallisepticum

Publications (2)

Publication Number Publication Date
WO1996034884A2 WO1996034884A2 (en) 1996-11-07
WO1996034884A3 true WO1996034884A3 (en) 1996-12-05

Family

ID=20431616

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SI1996/000011 Ceased WO1996034884A2 (en) 1995-05-05 1996-04-29 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use

Country Status (5)

Country Link
AU (1) AU5414096A (en)
DE (1) DE19681356T1 (en)
GB (1) GB2314560B (en)
SI (1) SI9500155A (en)
WO (1) WO1996034884A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9491598A (en) * 1997-09-19 1999-04-05 Synbiotics Corporation Methods for the diagnosis of feline infectious anemia
CN117964782B (en) * 2024-01-31 2024-12-03 扬州优邦生物药品有限公司 Genetically engineered fusion epitope subunit vaccine for preventing mycoplasma gallisepticum and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C.M.FALCOMER E.A.: "Chain reversals in model peptides...", J.AM.CHEM.SOC., vol. 114, no. 11, 1992, pages 4036 - 4042, XP002014933 *
P.F.MARKHAM E.A.: "Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of M. gallisepticum", INFECTION AND IMMUNITY, vol. 61, no. 3, March 1993 (1993-03-01), WASHINGTON US, pages 903 - 909, XP002014934 *

Also Published As

Publication number Publication date
GB2314560B (en) 1999-09-29
AU5414096A (en) 1996-11-21
WO1996034884A2 (en) 1996-11-07
GB2314560A (en) 1998-01-07
DE19681356T1 (en) 1998-08-20
SI9500155A (en) 1996-12-31
GB9723289D0 (en) 1998-01-07
GB2314560A8 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
EP1630229A3 (en) Melanoma antigens
EP0210628A3 (en) Antigenic modification of polypeptides
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
RU95105991A (en) Conjugate, vaccine, methods of immunogenicity enhancement, methods of immunization
CA2103887A1 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
NO308413B1 (en) Antigen mixture, DNA segment encoding an antigen, recombinant vector and host cell including the DNA segment and uses of an antigen
AU4055989A (en) Novel infectious bursal disease virus
WO1999006544A8 (en) Membrane-bound cytokine compositions and methods of modulating an immune response using same
WO2001096368A3 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
EP2311952A3 (en) Antibodies to MRT-1 protein or fragments thereof
EP2261358A3 (en) Novel streptococcus antigen
NZ219113A (en) Hiv peptide containing epitope of the env protein
NO913518L (en) VACCINES FOR NON-TYPE-TESTABLE HAEMOPHILUS INFLUENZAE.
EP1611897A3 (en) Whole or disrupted insect cells as adjuvant for antigens
KR910000183A (en) Recombinant Sporeworm Vaccine
NO902909D0 (en) T-CELL EPITOP AS A CARRIER MILK FOR CONJUGATE VACCINES.
WO2002026250A3 (en) Vaccines for proliferative ileitis
Jemmerson et al. Mapping antigenic sites on proteins: Implications for the design of synthetic vaccines.
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE302016T1 (en) PEPTIDES USED AS CARRIERS IN IMMUNOGENIC CONSTRUCTS USEFUL IN THE DEVELOPMENT OF SYNTHETIC VACCINES
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
CA2125486A1 (en) Platelet gpiiia p1 a1 and p1 a2 epitopes, their preparation and use
WO2023172741A3 (en) A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine comprising b- and t-cell antigens, immunogenic composition, and uses thereof
WO1996034884A3 (en) Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 1997 973239

Country of ref document: US

Date of ref document: 19971128

Kind code of ref document: A

122 Ep: pct application non-entry in european phase
RET De translation (de og part 6b)

Ref document number: 19681356

Country of ref document: DE

Date of ref document: 19980820

WWE Wipo information: entry into national phase

Ref document number: 19681356

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8607